VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VYNE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VYNEVYNE Therapeutics Inc.
$0.65$28M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVYNEQuarterly Financials

VYNE Therapeutics Inc. (VYNE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

VYNE Therapeutics Inc. (VYNE) quarterly income statement — complete revenue, gross profit & net income history

VYNE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue86K130K169K69K202K84K121K198K98K76K114K135K99K6K167K126K178K2.29M133K295K
Revenue Growth %-57.43%54.76%39.67%-65.15%106.12%10.53%6.14%46.67%-1.01%1166.67%-31.74%7.14%-44.38%-99.74%25.56%-57.29%-22.61%-46.52%-95.93%-97.48%
Cost of Goods Sold6K0000000000000000903K28K28K
COGS % of Revenue6.98%----------------39.4%21.05%9.49%
Gross Profit80K130K169K69K202K84K121K198K98K76K114K135K99K6K167K126K178K1.39M105K267K
Gross Margin %93.02%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%60.6%78.95%90.51%
Gross Profit Growth %-60.4%54.76%39.67%-65.15%106.12%10.53%6.14%46.67%-1.01%1166.67%-31.74%7.14%-44.38%-99.57%59.05%-52.81%-22.61%-62.98%-96.38%-97.67%
Operating Expenses3.9M5.35M7.96M7.61M9.4M12.85M13.21M10.59M7.48M6.91M6.35M10.45M5.97M7.99M9.5M8.41M8.87M-10.65M10.87M9.81M
OpEx % of Revenue4530.23%4114.62%4710.65%11030.43%4652.97%15302.38%10919.01%5350.51%7630.61%9089.47%5568.42%7742.96%6034.34%133166.67%5688.62%6676.98%4982.58%-464.88%8174.44%3325.08%
Selling, General & Admin3.08M2.37M2.71M2.73M3.27M3.17M2.96M3.29M3.77M3.88M3.03M3.22M3.24M3.71M3.95M4.3M4.42M8.2M4.96M4.76M
SG&A % of Revenue3580.23%1824.62%1600.59%3956.52%1621.29%3773.81%2449.59%1660.61%3846.94%5111.84%2657.89%2385.19%3272.73%61850%2367.66%3416.67%2481.46%357.68%3725.56%1613.9%
Research & Development817K2.98M5.26M4.88M6.12M9.68M10.25M7.31M3.71M3.02M3.32M7.23M2.73M4.28M5.55M4.11M4.45M5.24M5.92M5.05M
R&D % of Revenue950%2290%3110.06%7073.91%3031.68%11528.57%8469.42%3689.9%3783.67%3977.63%2910.53%5357.78%2761.62%71316.67%3320.96%3260.32%2501.12%228.4%4448.87%1711.19%
Other Operating Expenses00000000000000010-1000K00
Operating Income-3.82M-5.22M-7.79M-7.54M-9.2M-12.77M-13.09M-10.4M-7.38M-6.83M-6.23M-10.32M-5.88M-7.98M-9.33M-8.29M-8.69M12.04M-10.77M-9.54M
Operating Margin %-4437.21%-4014.62%-4610.65%-10930.43%-4552.97%-15202.38%-10819.01%-5250.51%-7530.61%-8989.47%-5468.42%-7642.96%-5934.34%-133066.67%-5588.62%-6576.98%-4882.58%525.48%-8095.49%-3234.58%
Operating Income Growth %58.51%59.13%40.48%27.45%-24.62%-86.91%-109.99%-0.76%-25.62%14.43%33.2%-24.51%32.4%-166.29%13.32%13.15%10.93%-97.51%-145.83%94.29%
EBITDA-3.81M-5.21M-7.79M-7.54M-9.19M-12.77M-13.09M-9.39M-7.38M-6.83M-6.22M-10.2M-5.83M-7.97M-9.16M-8.28M-8.65M12.07M-10.74M-9.51M
EBITDA Margin %-4430.23%-4010.77%-4607.1%-10921.74%-4550%-15202.38%-10819.01%-4744.95%-7530.61%-8989.47%-5452.63%-7552.53%-5892.34%-132766.67%-5486.23%-6567.46%-4857.87%526.61%-8074.44%-3225.08%
EBITDA Growth %58.55%59.17%40.52%19.79%-24.54%-86.91%-110.6%7.86%-26.51%14.24%32.15%-23.21%32.54%-166%14.68%13.02%11.13%-97.5%-145.59%94.31%
D&A (Non-Cash Add-back)6K5K6K6K6K001M0018K122.08K41.58K18K171K12K44K26K28K28K
EBIT-3.82M-5.22M-7.79M-7.54M-9.2M-12.77M-13.09M-10.4M-7.38M-6.83M-6.23M-10.04M-5.88M-7.98M-9.33M-8.29M-8.69M-12.02M-10.8M-9.61M
Net Interest Income000000000000000000-3.47M-1.07M
Interest Income00000000000000000000
Interest Expense0000000000000000003.47M1.07M
Other Income/Expense231K263K366K1.79M594K760K934K1M1.14M680K163K280K263K236K78K52K-3K-24.06M-3.51M-1.14M
Pretax Income-3.58M-4.96M-7.43M-5.75M-8.6M-12.01M-12.16M-9.39M-6.24M-6.15M-6.07M-10.04M-5.61M-7.75M-9.26M-8.23M-8.69M-12.02M-14.28M-10.69M
Pretax Margin %-4168.6%-3812.31%-4394.08%-8328.99%-4258.91%-14297.62%-10047.11%-4744.95%-6368.37%-8094.74%-5325.44%-7435.56%-5668.69%-129133.33%-5541.92%-6535.71%-4884.27%-524.35%-10733.83%-3622.03%
Income Tax04K0004K000000013K000-448K00
Effective Tax Rate %0%-0.08%0%0%0%-0.03%0%0%0%0%0%0%0%-0.17%0%0%0%3.73%0%0%
Net Income-3.58M-4.84M-7.28M-5.75M-8.61M-12.02M-12.16M-9.41M-6.25M-6.19M-6.58M-10.06M-5.62M-9.95M-9.46M-8.48M4.67M-11.57M-21.29M-19.92M
Net Margin %-4168.6%-3720.77%-4307.69%-8340.58%-4262.87%-14311.9%-10047.11%-4750.51%-6376.53%-8142.11%-5775.44%-7450.37%-5678.79%-165750%-5664.07%-6726.98%2623.6%-504.8%-16003.76%-6753.9%
Net Income Growth %58.37%59.77%40.12%38.82%-37.8%-94.28%-84.64%6.48%-11.15%37.78%30.39%-18.66%-220.39%14.04%55.56%57.46%122.73%50.09%13.87%88.1%
Net Income (Continuing)-3.58M-4.96M-7.43M-5.75M-8.6M-12.01M-12.16M-9.39M-6.24M-6.15M-6.07M-10.04M-5.61M-7.76M-9.26M-8.23M-8.69M-11.57M-14.28M-10.69M
Discontinued Operations0123K146K-8K-8K-8K0-11K-8K-36K-513K-20K-10K-1000K-204K-241K1000K0-1000K-1000K
Minority Interest00000000000000000000
EPS (Diluted)-0.08-0.10-0.17-0.13-0.20-0.28-0.29-0.22-0.15-0.20-2.01-3.08-1.72-2.60-2.94-2.631.52-3.89-7.36-6.98
EPS Growth %58.1%64.29%41.38%40.91%-33.33%-40%85.57%92.86%91.28%92.31%31.63%-17.11%-213.16%33.16%60.05%62.32%120.08%54.45%30.63%91.97%
EPS (Basic)-0.08-0.10-0.17-0.13-0.20-0.28-0.29-0.22-0.15-0.20-2.01-3.08-1.72-2.60-2.94-2.631.52-3.89-7.36-6.98
Diluted Shares Outstanding42.77M42.77M42.74M42.76M42.67M42.59M42.59M42.59M42.58M31.05M3.28M3.27M3.26M2.98M3.22M3.22M3.08M2.97M2.89M2.86M
Basic Shares Outstanding42.77M42.77M42.74M42.76M42.67M42.59M42.59M42.59M42.58M31.05M3.28M3.27M3.26M2.98M3.22M3.22M3.08M2.97M2.89M2.86M
Dividend Payout Ratio--------------------